We did not identify any RBP which uniquely target either the exosomal or the cellular lncRNAs, however there is a significant difference in the number of binding sites for RBMX, ELAVL1 and SFRS1 in the exosomal lncRNAs compared to cellular lncRNAs of both healthy and cancer cell lines. Here, ELAVL1 is linked to cancer.